CCL5 mediates target‐kinase independent resistance to FLT3 inhibitors in FLT3‐ITD‐positive AML

por Waldeck, Silvia, Rassner, Michael, Keye, Philip, Follo, Marie, Herchenbach, Dieter, Endres, Cornelia, Charlet, Anne, Andrieux, Geoffroy, Salzer, Ulrich, Boerries, Melanie, Duyster, Justus, von Bubnoff, Nikolas
Publicado no Mol Oncol (2020)

­­LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation

por Zinngrebe, Julia, Rieser, Eva, Taraborrelli, Lucia, Peltzer, Nieves, Hartwig, Torsten, Ren, Hongwei, Kovács, Ildikó, Endres, Cornelia, Draber, Peter, Darding, Maurice, von Karstedt, Silvia, Lemke, Johannes, Dome, Balazs, Bergmann, Michael, Ferguson, Brian J., Walczak, Henning
Publicado no J Exp Med (2016)